An interventional study of Diaphragmatic Pacing Therapy DPTS in Ventilator Induced Diaphragm Dysfunction, sponsored by Lungpacer Medical Inc.. Completed at 21 sites in 2 countries. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2022-11-16.
Sponsored by Lungpacer Medical Inc. · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
A randomized clinical trial to investigate the use of the temporary Diaphragm Pacing Therapy System (DPTS) to rehabilitate the diaphragm in mechanically ventilated patients who have failed at least two weaning attempts. The goal is to strengthen and rehabilitate the diaphragm to liberate the patient more quickly from mechanical ventilation.
Mechanical ventilation (MV) is a life saving technology but can also cause damage to the lungs and diaphragm such as ventricular induced diaphragmatic dysfunction (VIDD). Research has shown that after being on mandatory MV and sedated the diaphragm begins to atrophy within as short as 18 hours. The Lungpacer Diaphragm Pacing Therapy System (DPTS) is a temporary therapy that consists of the Lungpacer IntraVenous Electrode Catheter (LIVE Catheter) and the Lungpacer Control Unit system. The LIVE Catheter is a proprietary central venous catheter that incorporates pacing electrodes in strategic areas that align with the left and right phrenic nerves. The LIVE Catheter can also be used for fluid delivery like any other central venous catheter. The randomized clinical trial will investigate the safety, effectiveness and performance of the Lungpacer DPTS. By stimulating the diaphragm through daily therapy sessions, with the intention of exercising and rehabilitating the diaphragm muscle so the patient may be able to be more quickly liberated from MV. The patient population includes those who have been mechanically ventilated for greater than or equal to 96 hours (4days), have failed two or more spontaneous breathing trials (SBT), and were not hypervolemic during the latest spontaneous breathing trial. Patients must have resolution of the initial indication for placement on mechanical ventilation before entering the trial.
Lungpacer Medical Inc. is the lead sponsor of 8 studies on the registry; 2 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
The study doctor’s estimate of how long someone is likely to live. Criteria use it so that people can stay in the study long enough for it to answer its question.
BMI (body mass index)
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Life expectancy
The study doctor’s estimate of how long someone is likely to live. Criteria use it so that people can stay in the study long enough for it to answer its question.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Diaphragm Pacing intervention will be conducted 2x a day using the Diaphragmatic Pacing Therapy System (DPTS). The DPTS includes the Lungpacer IntraVenous Electrode Catheter (LIVE Catheter) which is inserted temporarily into the left subclavian vein, the Lungpacer Control Unit (LCU external unit) and an intermediate cable that connects the LCU to the LIVE Catheter.
Device: Diaphragmatic Pacing Therapy DPTS
Standard of care treatment of weaning failure, no intervention is involved in this control group.
Subjects will undergo DPTS 2 times a day until successfully extubated with no reintubation within 48 hours.
Also known as: DPTS, LIVE Catheter
Proportion successfully weaned by 30 days for subjects randomized to Treatment (Lungpacer DPTS) as compared to subjects randomized to Control.
"Successfully weaned" is defined as passing the protocol-specific Ventilator Liberation Trial (VLT), or removed from MV, and not reintubated (subjects with an oral or nasal, endotracheal tube) or returned to MV (subjects with a tracheostomy) within 48 hours
Time frame: Patients will be allowed to stay in the study for up to 30 (+2 days of follow up for adverse events) days if not removed from mechanical ventilation sooner
Days on mechanical ventilation
Days on mechanical ventilation from randomization to removal from MV associated with successful weaning or Day 30, whichever comes first
Time frame: from randomization to 30 days
Changes in diaphragmatic thickening fraction on diaphragm ultrasound
Evaluate difference in changes in diaphragmatic thickening fraction between study allocation groups from randomization to successful weaning or on day 30 whichever comes first;
Time frame: to successful weaning or on day 30 which ever comes first.
Changes in MIP
Change in MIP from randomization to last available measure; Change in MIP over time from randomization (baseline).
Time frame: to successful weaning, or on day 30, whichever comes first.
Change in MIP
Rate of MIP change per day from randomization (baseline) to last available measure;
Time frame: to successful weaning, or on day 30 whichever comes first.
Changes in RSBI
Change in RSBI from randomization (baseline) to last available measure; Change in RSBI over time from randomization (baseline);
Time frame: to successful weaning, or on day 30, whichever comes first
Change in RSBI
Rate of RSBI change per day from randomization (baseline) to last available measure;
Time frame: to successful weaning, or on day 30, whichever comes first
Mortality
30-day mortality
Time frame: on day 30
Weaning from and re-installation of Mechanical Ventilation in both groups
Cessations and re-instatements of mechanical ventilation to Day 30 or Study Exit
Time frame: from randomization to 30 days
Tracheostomy
Proportion of subjects tracheotomized from randomization to study exit
Time frame: from randomization to 30 days
Ventilator settings
Pressure Support daily, to last available measure
Time frame: from randomization to 30 days
Ventilator settings
PEEP daily, to last available measure
Time frame: from randomization to 30 days
Ventilator settings
Ventilation Mode daily, to last available measure
Time frame: from randomization to 30 days
Ventilator settings
Tidal Volume daily, to last available measure
Time frame: from randomization to 30 days
Number of ICU admissions and discharges through D30 for both groups
ICU admissions and discharges to day 30
Time frame: from randomization to 30 days
Number of hospital admissions and discharges through D30 for both groups
Hospital admissions and discharges to day 30.
Time frame: from randomization to 30 days
Plan to share: Undecided — Only investigators participating in this clinical trial will be able to see final de-identified participant data at the completion of the study and it will be available through the clinical research organization (CRO).
Ran from Sep 2017 to primary completion in Dec 2019, 27 months.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Nov 2022. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Lungpacer Medical Inc.